BridgeBio Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
BridgeBio Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • BridgeBio Pharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 189M shares, a 15.4% increase year-over-year.
  • BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 163M shares, a 10.4% increase from 2022.
  • BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 147M shares, a 2.16% increase from 2021.
  • BridgeBio Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 144M shares, a 22.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 189M +25.2M +15.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 188M +27.1M +16.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 179M +26.1M +17.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 163M +15.3M +10.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 163M +15.4M +10.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 161M +13.9M +9.44% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 153M +6.76M +4.64% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 147M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 148M +1.28M +0.87% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 147M -69.5K -0.05% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 146M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 147M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 147M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.